Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | 12-2008 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 27,447 | 8,293 | N/A | N/A |
| Receivables | 1,191 | 1,455 | N/A | N/A |
| Inventories | 1,605 | 1,729 | N/A | N/A |
| TOTAL | $31,055 | $12,549 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 23,950 | 19,560 | N/A | N/A |
| Intangibles | 8,912 | 11,178 | 0 | 0 |
| Other Non-Current Assets | 2,645 | 667 | 0 | 0 |
| TOTAL | $35,507 | $31,405 | $N/A | $N/A |
| Total Assets | $66,562 | $43,954 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 3,182 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 4,315 | 6,994 | 0 | 0 |
| Accrued Expenses | 4,983 | 3,478 | 0 | N/A |
| Other current liabilities | 1,575 | 1,599 | 0 | N/A |
| TOTAL | $16,322 | $14,417 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 71,664 | 22,173 | N/A | N/A |
| Deferred Revenues | 2,267 | 2,346 | N/A | N/A |
| Other Non-Current Liabilities | 8,821 | 8,749 | 0 | 0 |
| TOTAL | $98,623 | $52,486 | $N/A | $N/A |
| Total Liabilities | $114,945 | $66,903 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | 1 | 0 | N/A |
| Retained earnings | -136,911 | -109,762 | N/A | N/A |
| Other shareholders' equity | -2 | 0 | 0 | 0 |
| TOTAL | $-48,383 | $-22,949 | $N/A | $N/A |
| Total Liabilities And Equity | $66,562 | $43,954 | $0 | $0 |